This project is the first scholarship in Australia to support a dedicated Doctor of Medical Science scholar to focus on describing, understanding and improving diagnosis of Bone Marrow Failure Syndromes using genomics evaluation. More accurate diagnosis of Bone Marrow Failure Syndromes using genomics evaluation underpins targeted treatment/s which will be associated with a greater chance of cure while avoiding harms and costs of inappropriate therapies. Working closely with the Aplastic Anaemia Registry (AAR) team, this new research role will also provide a valuable clinical resource to the AAR project team and contribute to analysis of Australian data for presentation and publication.
2017-2021 Flavorite Fellowship, Genome editing of haematopoietic stem and progenitor cells to uncover novel therapeutics for Aplastic Anaemia and other Bone Marrow Failure Syndromes, Dr Yih-Chih Chan, The University of Melbourne and Peter ...
Read more2023- 2025 (Fellowship): The inaugural Captain Courageous Fellowship. A preclinical trial of next generation gene editing for the prevention of bone marrow failure in Fanconi Anaemia. Dr Astrid Glaser at the Genome Stability Unit of St Vincent’s ...
Read more2019-2021 (Fellowship): The Alex Gadomski Fellowship. Functional interrogation of Loci associated with the regulation of haematopoiesis. Dr Kirsten Fairfax, Menzies Institute for Medical Research and University of Tasmania. To understand bone ...
Read more2019-2023 (co-funded Snowdome/Gunn Family/Maddie Riewoldt’s Vision) The Gunn Family National Fellowship for Career Development in Research – Women in Haematology. Novel blood biomarkers for predicting bone marrow failure in Myeloproliferative ...
Read more